Renal disease in patients with HIV

Current Infectious Disease Reports

Volumn 8, Issue 1, 2006, Pages 76-81

  Wyatt, Christina M ^a   Winston, Jonathan ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADEFOVIR; AMPHOTERICIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVIRUS AGENT; CIDOFOVIR; CORTICOSTEROID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDINAVIR; INTERFERON; NUCLEOSIDE DERIVATIVE; PENTAMIDINE; RIBAVIRIN; TENOFOVIR; TRIMETHOPRIM;

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; ETHNOLOGY; FANCONI RENOTUBULAR SYNDROME; FOCAL GLOMERULOSCLEROSIS; GENETIC RISK; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKALEMIA; HYPERTENSION; HYPOCALCEMIA; HYPONATREMIA; HYPOVOLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY BIOPSY; KIDNEY DISEASE; LACTIC ACIDOSIS; LIVER TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MORBIDITY; MORTALITY; NEPHROGENIC DIABETES INSIPIDUS; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PNEUMOCYSTOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VASCULAR ACCESS; VIRUS LOAD; VIRUS VIRULENCE;

EID: 31544439365     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0038-0     Document Type: Review

References (49)

1. Selik RM, Byers RH Jr, Dworkin MS: Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002, 29:378-387.
2. Gardenschwartz MH, Lerner CW, Seligson GR, et al.: Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 1984, 21:197-204.
3. Pardo V, Aldana M, Colton RM, et al.: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984, 101:429-434.
4. Rao TK, Filippone EJ, Nicastri AD, et al.: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984, 310:669-673.
5. D'Agati V, Appel GB: Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998, 18:406-421.
6. Boccia RV, Gelmann EP, Baker CC, et al.: A hemolytic uremic syndrome with acquired immunodeficiency syndrome. Ann Intern Med 1984, 101:716-717.
7. Bachmeyer C, Blanche P, Sereni D, et al.: Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in HIV-infected patients. AIDS 1995, 9:532-533.
8. United States Renal Data System (USRDS): USRDS 2004 annual data report: Atlas of end-stage renal disease in the United States. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
9. Schwartz Ej, Szczech LA, Ross MJ, et al.: Highly active Antiretroviral rherapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 2005, 16:2412-2420.
10. Szczech LA, Gange SJ, van der Horst C, et al.: Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002, 61:195-202.
11. Franceschini N, Napravnik S, Eron Jj, et al.: Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int 2005, 67:1526-1531.
12. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int 1999, 56:2203-2213.
13. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999, 10:51-61.
14. Dickie P, Felser J, Eckhaus M, et al.: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991, 185:109-119.
15. Bruggeman LA, Dikman S, Meng C, et al.: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997, 100:84-92.
16. Bruggeman LA, Ross MD, Tanji N, et al.: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000, 11:2079-2087.
17. Ross MJ, Bruggeman LA, Wilson PA, Klotman PE: Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. J Am Soc Nephrol 2001, 12:2645-2651.
18. Winston JA, Bruggeman LA, Ross MD, et al.: Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001, 344:1979-1984.
19. Abbott KC, Hypolite I, Welch PG, Agodoa LY: Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 2001, 14:377-383.
20. Freedman BI, Soucie IM, Stone SM, Pegram S: Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 1999, 34:254-258.
21. Gharavi AG, Ahmad T, Wong RD, et al.: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 2004, 101:2488-2493.
22. Lucas GM, Eustace JA, Sozio S, et al.: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004, 20:541-516.
23. Wali RK, Drachenberg CI, Papadimitriou JC, et al.: HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998, 352:783-784.
24. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and renal disease: an update. Am J Kidney Dis 2003, 42:631-657.
25. Chen J, Anderson HL, Markowitz GS, et al.: Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999, 10:1566-1574.
26. Szczech LA, Gupta SK, Habash R, et al.: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004, 66:1145-1152.
27. Gupta SK, Eustace JA, Winston JA, et al.: Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infectious Dis 2005, 40:1559-1585.
28. Ahuja TS, Collinge N, Grady J, Khan S: Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy? Am J Kidney Dis 2003, 41:1060-1064.
29. Ahuja TS, Grady J, Khan S: Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. Am J Kidney Dis 2002, 13:1889-1893.
30. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL: Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004, 15:1633-1639.
31. Stock PG, Roland ME, Carlson L, et al.: Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003, 76:370-375.
32. Kumar MSA, Sierka DR, Damask AM, et al.: Safety and !uccess of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Transplantation 2005, 67:1622-1629.
33. Grabe DW, Eisele G, Miller C, et al.: Indinavir-induced nephropathy. Clin Nephrol 1999, 51:181-183.
34. Martinez F, Mommeja-Marin H, Estepa-Maurice L, et al.: Indinavir crystal deposits associated with tubulointerstitial nephropathy. Nephrol Dial Transplant 1998, 13:750-753.
35. Becker BN, Fall P, Hall C, et al.: Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature. Am J Kidney Dis 1993, 22:611-615.
36. Purohit N, Durr J, Lopez R: Cidofovir-induced Fanconi syndrome and nephrogenic diabetes insipidus. Am J Kidney Dis 2002, 39:26.
37. Verhelst D, Monge M, Meynard JL, et al.: Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002, 40:1331-1333.
38. Peyriere H, Reynes J, Rouanet I, et al.: Renal tubular dysfunction associated with tenofovir therapy: Report of 7 cases. J Acquir Immune Defic Syndr 2004, 35:269-273.
39. Barrios A, Garcia-Benayas T, Gonzalez-Lahoz J, Soriano V: Tenofovir-related nephrotoxicity in HIV-infected patients. AIDS 2004, 18:960-963.
40. Lewis W, Dalakas MC: Mitochondrial toxicity of antiviral drugs. Nat Med 1995, 1:417-422.
41. Cote HCF, Brumme ZL, Craib KJP, et al.: Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002, 346:811-820.
42. Moreno A, Quereda C, Moreno L, et al.: High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin. Antivir Ther 2004, 9:133-138.
43. Miro O, Lopez S, Martinez E, et al.: Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin Infect Dis 2004, 39:710-716.
44. John M, Moore CB, James IR, et al.: Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 2001, 15:717-723.
45. Tang WW, Kaptein EM, Feinstein EI, Massry SG: Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med 1993, 94:169-174.
46. Cusano Aj, Thies HL, Siegal FP, et al.: Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1990, 3:949-953.
47. Piedrola G, Casado JL, Lopez E, et al.: Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endcrinol 1996, 45:97-101.
48. Peraldi MN, Maslo C, Akposso, K, et al.: Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol Dial Transplant 1999, 14:1578-1585.
49. Rao TK, Friedman EA: Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome. Am J Kidney Dis 1995, 25:390-398.